JP2013075888A - Organ preservation device - Google Patents

Organ preservation device Download PDF

Info

Publication number
JP2013075888A
JP2013075888A JP2012197158A JP2012197158A JP2013075888A JP 2013075888 A JP2013075888 A JP 2013075888A JP 2012197158 A JP2012197158 A JP 2012197158A JP 2012197158 A JP2012197158 A JP 2012197158A JP 2013075888 A JP2013075888 A JP 2013075888A
Authority
JP
Japan
Prior art keywords
organ
preservation
temperature
preserving
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012197158A
Other languages
Japanese (ja)
Inventor
Hiromichi Obara
弘道 小原
Naoto Matsuno
直徒 松野
Hiroshi Mizunuma
博 水沼
Toshihiko Hirano
俊彦 平野
Shin Enosawa
伸 絵野沢
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tokyo Metropolitan Public University Corp
Original Assignee
Tokyo Metropolitan Public University Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Metropolitan Public University Corp filed Critical Tokyo Metropolitan Public University Corp
Priority to JP2012197158A priority Critical patent/JP2013075888A/en
Publication of JP2013075888A publication Critical patent/JP2013075888A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide an organ preservation device for preserving an organ which is taken out from a living body, which can select an optimum preserving condition for the organ by analyzing the condition of the organ during preservation.SOLUTION: The organ preservation device includes: an organ preserving part (19) for preserving an organ (18); a preserving liquid perfusion part (20) for perfusing the organ (18) preserved in the organ preserving part with preserving liquid for preserving organs; a temperature control part for controlling the temperature of the organ preserving part; an introduction part (21) for introducing an active component agent into the preserving liquid circulating through the preserving liquid perfusion part (20); a function-evaluating part for evaluating functions of the organ by measuring the rate of flow of the preserving liquid perfusing the organ (18); and an adjusting part (33) for adjusting the temperature of the temperature control part, the type and the introduction amount of the active component agent introduced from the introduction part (21), and the rate of flow of the preserving liquid based on the data obtained by the function-evaluation.

Description

本発明は、ヒトなどの哺乳動物の生体から取り出した臓器を保存し、且つ保存中の臓器の状態を解析して最適な保存状態を選択できる臓器保存装置である。   The present invention is an organ storage device that can store an organ taken out of a living body of a mammal such as a human and analyze the state of the organ being stored and select an optimal storage state.

生体から取り出した臓器を保存する装置は種々提案されており、例えば、特許文献1において、図1に示す保存装置が提案されている。すなわち、保存溶液中で肝臓移植片(1)を保存する、容器(2)、動脈灌流回路(3)、門脈灌流回路(5)、少なくとも1つの流量センサー(7)、及び少なくとも1つの圧力センサー(8)を備え、肝臓移植片(1)の保存を向上するために、さらに、動脈灌流回路(3)に連結した動脈酸素供給器(11)、門脈灌流回路(5)に連結した門脈酸素供給器(12)、少なくとも1つの動脈灌流ポンプ(9)、少なくとも1つの門脈灌流ポンプ(10)、容器(2)内部の温度を正常体温に維持するように構成された温度変換モジュール(13)、及び圧力及び流量制御装置(14)を備える装置が提案されている。
かかる装置では、正常体温条件において肝臓又は肝臓移植片を保存することができるように、温度や流通させる液体の圧力や流量を調節できるようになっている。
Various apparatuses for storing an organ taken out from a living body have been proposed. For example, Patent Document 1 proposes a storage apparatus shown in FIG. A container (2), an arterial perfusion circuit (3), a portal perfusion circuit (5), at least one flow sensor (7), and at least one pressure, storing the liver graft (1) in a preservation solution In order to improve the preservation of liver graft (1) with sensor (8), it was further connected to arterial oxygenator (11) connected to arterial perfusion circuit (3), portal perfusion circuit (5) Temperature conversion configured to maintain the temperature inside the portal oxygenator (12), at least one arterial perfusion pump (9), at least one portal perfusion pump (10), and the container (2) at normal body temperature A device comprising a module (13) and a pressure and flow control device (14) has been proposed.
In such a device, the temperature and the pressure and flow rate of the liquid to be circulated can be adjusted so that the liver or liver graft can be stored under normal body temperature conditions.

特表2011−520839号公報Special table 2011-520839 gazette

しかし、上述の提案にかかる臓器保存装置では、単にあらかじめ定められた条件で保存を行うのみであり、いざ使用する段階において保存した臓器の状態が移植に適していないと判明してしまう場合もあった。
すなわち、従来提案されている臓器保存装置では臓器を単に保存するのみであり、移植に適しているか否かまではわからないのが現状であり、保存している臓器が移植に適しているのか否かを判別でき、さらには移植に適した状態を保持できるようにすることができる臓器保存装置の提供が要望されている。
したがって本発明は、生体から取り出した臓器を保存し、且つ保存中の臓器の状態を解析して最適な保存状態を選択できる臓器保存装置を提供することを目的とする。
However, the organ storage device according to the above-mentioned proposal merely performs storage under predetermined conditions. In some cases, the stored organ state is not suitable for transplantation. It was.
In other words, the organ preservation device that has been proposed in the past only preserves the organ, and it is currently unknown whether it is suitable for transplantation. Whether the stored organ is suitable for transplantation or not. There is a need to provide an organ preservation device that can discriminate between them and can maintain a state suitable for transplantation.
Accordingly, an object of the present invention is to provide an organ storage device that can store an organ taken out of a living body and analyze the state of the organ being stored to select an optimal storage state.

本発明者らは上記課題を解消すべく鋭意検討した結果、保存している臓器に灌流させる保存液の流量や圧力を測定し、あらかじめ設定したデータベースまたはプログラムされた制御則や評価基準に照合することで臓器の状態を把握できることを知見し、本発明を完成するに至った。
すなわち、本発明は以下の装置を提供するものである。
生体から分離した臓器を灌流保存する臓器保存装置であって、
臓器を保持する臓器保持部と、
該臓器保持部に保持されている臓器に臓器保存用の保存液を灌流させる保存液灌流部と、
臓器保存部の温度管理を行う温度管理部と、
保存液灌流部に流通させる保存液に有効成分剤を導入する導入部と、
臓器に灌流させる保存液の流量や圧力を測定することで臓器の機能を評価する機能評価部と、
機能評価により得られたデータに基づいて温度管理部の温度、並びに導入部により導入される有効成分剤の種類や導入量及び該保存液の流量を調節する調整部と
を具備してなる臓器保存装置、である。
本発明において保存することができる臓器としては、肝臓、腎臓、心臓、小腸、すい臓等が挙げられ、特に肝臓に好ましく適用できる。
また、本発明は、上記温度管理部は、上記臓器保存部内に貯留される保存液の温度を4℃〜25℃まで徐々に加温及び/又は冷却するように温度制御することを特徴とする上記臓器保存装置を提供するものである。
また、上記臓器保存装置を用いる臓器保存方法であって、臓器保存部の温度を4℃〜25℃まで徐々に加温及び/又は冷却することを特徴とする臓器保存方法を提供するものである。
As a result of intensive studies to solve the above-mentioned problems, the present inventors have measured the flow rate and pressure of a preservation solution to be perfused into a preserved organ and collated it with a preset database or a programmed control law and evaluation standard. As a result, it was found that the state of the organ can be grasped, and the present invention has been completed.
That is, the present invention provides the following devices.
An organ preservation device for perfusion preservation of an organ separated from a living body,
An organ holding unit for holding the organ;
A preservation solution perfusion section for perfusing an preservation solution for organ preservation to the organ held in the organ holding section;
A temperature management unit for managing the temperature of the organ preservation unit;
An introduction part for introducing an active ingredient into a preservation solution to be distributed to the preservation solution perfusion part;
A function evaluation unit that evaluates the function of the organ by measuring the flow rate and pressure of the preservation solution to be perfused into the organ;
Organ preservation comprising a temperature control part based on data obtained by functional evaluation, and an adjustment part for adjusting the type and amount of active ingredient introduced by the introduction part and the flow rate of the preservation solution Device.
Examples of organs that can be preserved in the present invention include liver, kidney, heart, small intestine, pancreas and the like, and can be preferably applied particularly to the liver.
Further, the present invention is characterized in that the temperature management unit controls the temperature of the preservation solution stored in the organ preservation unit so as to gradually warm and / or cool the temperature of the preservation solution from 4 ° C. to 25 ° C. The organ preservation apparatus is provided.
The present invention also provides an organ preservation method using the above organ preservation device, characterized by gradually heating and / or cooling the temperature of the organ preservation part from 4 ° C. to 25 ° C. .

本発明の臓器保存装置によれば、生体から取り出した臓器を保存し、且つ保存中の臓器の状態を解析して最適な保存状態を選択できるので、生体から取り出した臓器を単に劣化しないように保存するのではなく、臓器が仮に劣化したとしてもかかる劣化部分の修復が可能であれば修復を行い、臓器を移植に適した状態に保持することが可能である。   According to the organ preservation device of the present invention, an organ taken out from a living body can be preserved, and an optimal preservation state can be selected by analyzing the state of the organ being preserved, so that the organ taken out from the living body is not simply deteriorated. Rather than storing, even if the organ has deteriorated, if the deteriorated portion can be repaired, it can be repaired and the organ can be held in a state suitable for transplantation.

従来の臓器保存装置を示す概略図である。It is the schematic which shows the conventional organ preservation apparatus. 本発明の実施形態を示す斜視図である。It is a perspective view which shows embodiment of this invention. 流量計から得られる灌流流量情報及び灌流圧力情報の処理のフローである。It is a flow of processing of perfusion flow rate information and perfusion pressure information obtained from a flow meter. 実施例1〜3において行った臓器保存において、保存液中に放出されたラクトースデハイドロゲナーゼ(LDH)量を示すグラフである。It is a graph which shows the amount of lactose dehydrogenase (LDH) released | released in the preservation | save liquid in the organ preservation | save performed in Examples 1-3.

18 臓器
19 臓器保持部
20 保存液灌流部
21 導入部
22 ポンプ
23 エアトラップ
24 酸素添加管理部
25 流量計
26 圧力センサ
27 バルブ
28 エアトラップ
29 温度測定部
30 熱交換部
31 ポンプ
32 フィルター
33 調整部
18 organ 19 organ holding unit 20 preservation solution perfusion unit 21 introduction unit 22 pump 23 air trap 24 oxygen addition management unit 25 flow meter 26 pressure sensor 27 valve 28 air trap 29 temperature measurement unit 30 heat exchange unit 31 pump 32 filter 33 adjustment unit

以下、本発明を、図面を参照して詳細に説明するが、本発明はこれらに制限されるものではない。   Hereinafter, the present invention will be described in detail with reference to the drawings, but the present invention is not limited thereto.

本実施形態の臓器保存装置は、生体から分離した臓器を灌流保存する臓器保存装置であり、図2に示すように、
臓器(18)を保持する臓器保持部(19)と、
該臓器保持部に保持されている臓器(18)に臓器保存用の保存液を灌流させる保存液灌流部(20)と、
臓器保存部の温度管理を行う温度管理部と、
保存液灌流部(20)に流通させる保存液に有効成分剤を導入する導入部(21)と、
臓器(18)に灌流させる保存液の流量を測定することで臓器の機能を評価する機能評価部と、
機能評価により得られたデータに基づいて温度管理部の温度、並びに導入部(21)により導入される有効成分剤の種類や導入量及び該保存液の流量を調節する調整部(33)と
を具備してなる。図2では、具体的には、門脈や肝動脈の循環ができるようにした臓器保存装置を示している。
なお、保存液としては、ウィスコンシン液[University of Wisconcin
(UW) solution](前記特許文献1、特開平7−330501)などが挙げられる。
The organ preservation device of the present embodiment is an organ preservation device for perfusion preservation of an organ separated from a living body, and as shown in FIG.
An organ holding part (19) for holding the organ (18);
A preservation solution perfusion section (20) for perfusing a preservation solution for organ preservation to the organ (18) held in the organ holding section;
A temperature management unit for managing the temperature of the organ preservation unit;
An introduction part (21) for introducing an active ingredient into a preservation solution to be circulated through the preservation solution perfusion part (20);
A function evaluation unit that evaluates the function of the organ by measuring the flow rate of the preservation solution to be perfused into the organ (18);
An adjustment unit (33) for adjusting the temperature of the temperature management unit, the type and amount of the active ingredient introduced by the introduction unit (21), and the flow rate of the preservation solution based on the data obtained by the function evaluation; It has. FIG. 2 specifically shows an organ preservation device that enables circulation of the portal vein and hepatic artery.
In addition, Wisconsin solution [University of Wisconcin]
(UW) solution] (Patent Document 1, JP-A-7-330501).

以下、さらに詳細に説明する。
臓器保持部(19)は、一面が開口とされており、且つ中空の長方体状の箱体からなり、内部に保存液に浸漬された臓器(本実施形態においては肝臓(18))が載置されようになされている。開口はここでは特に図示しないが開閉自在の蓋が設けられていてもよい。
また、臓器保持部(19)中の溶液のpHはpH測定器により測定され、前記臓器保持部(19)中の溶液の溶存酸素量は溶存酸素濃度計(Do計)により測定される。
This will be described in more detail below.
The organ holding part (19) has an opening on one side and is formed of a hollow rectangular box, and an organ (liver (18) in the present embodiment) immersed in a preservation solution is contained therein. It is supposed to be placed. Although the opening is not particularly shown here, a lid that can be freely opened and closed may be provided.
Further, the pH of the solution in the organ holding part (19) is measured by a pH meter, and the dissolved oxygen amount of the solution in the organ holding part (19) is measured by a dissolved oxygen concentration meter (Do meter).

保存液灌流部(20)は、臓器(18)に保存液を導入する導入管部と臓器から保存液を排出する排出管部とからなる。
導入管部は、臓器保存部の内部に注入されている保存液を臓器内に導入するための部分であり、移送ポンプと、一端が移送ポンプに連結され且つ他端が臓器保存部内の保存液に浸漬された抽出管と、一端が移送ポンプに連結され且つ他端が臓器に連結された導入管と、抽出管に配されたエアトラップ(23、28)及び酸素添加装置(24)と、導入管に配された流量計(25)、圧力センサ(26)及びバルブ(27)とからなる。
排出管部は、臓器内部に注入された保存液を臓器外部に排出するための部分であり、移送ポンプと、一端が移送ポンプに連結され且つ他端が臓器保存部内に設けられた排出管と、一端が移送ポンプに連結され且つ他端が臓器に連結された導出管と、導出管に配されたエアトラップ(23、28)、流量計(25)、圧力センサ(26)及びバルブ(27)とからなる。
図2において、肝動脈循環用の管と門脈用循環用の管を明示した。図2において、肝動脈循環用の管と門脈用循環用の管での上述の保存液の流れを矢印で示している。
The preservation liquid perfusion section (20) includes an introduction pipe section for introducing the preservation liquid into the organ (18) and a discharge pipe section for discharging the preservation liquid from the organ.
The introduction tube part is a part for introducing the preservation solution injected into the organ preservation unit into the organ, and the transfer pump, one end of which is connected to the transfer pump and the other end is the preservation solution in the organ preservation unit. An extraction tube immersed in the tube, an introduction tube having one end connected to a transfer pump and the other end connected to an organ, an air trap (23, 28) and an oxygenator (24) disposed in the extraction tube, It consists of a flow meter (25), a pressure sensor (26) and a valve (27) arranged in the introduction pipe.
The drainage pipe part is a part for draining the preservation solution injected into the organ to the outside of the organ, a transfer pump, and a drainage pipe having one end connected to the transfer pump and the other end provided in the organ preservation part. A lead-out tube having one end connected to the transfer pump and the other end connected to the organ, an air trap (23, 28), a flow meter (25), a pressure sensor (26), and a valve (27) arranged in the lead-out tube ).
In FIG. 2, a hepatic artery circulation tube and a portal circulation tube are clearly shown. In FIG. 2, the flow of the above-described preservation solution in the hepatic artery circulation tube and the portal vein circulation tube is indicated by arrows.

温度管理部は、温度測定部(29)と、保存液を加熱冷却する熱交換部(30)と、温度測定部からのデータを基に設定した温度に調整するための信号を熱交換部に伝達する調整部の中央プロセッサ(図示せず)とからなる。温度測定部(29)は通常の熱電対式の温度計で構成することができ、熱交換部は、保存液を循環させるための配管を通じて保存液を加熱冷却できるようになされており、通常の加熱機構や冷却機構を特に制限なく用いることができる。また配管には、ポンプ(31)及び保存液から不純物を除去するフィルター(32)が設けられている。
この際、温度管理部(29)は、臓器保存部(19)内に貯留される保存液の温度を所定の温度に徐々に加温及び/又は冷却するように温度制御する。
上記の所定の温度は、4℃から25℃であるのが好ましい。
温度制御は、4℃の状態から25℃まで温度を徐々に上昇させることより行い、具体的には、保存液の温度上昇の速度が全温度制御時間における平均速度(全温度変化分/全温度制御時間)で0.15〜0.25℃/分、各単位時間当たりの温度変化量(ある単位分当たりの温度変化量)として1.5℃/分から0.01℃/分となるようになめらかに温度制御することが好ましい。
上記温度制御は、調整部(33)が温度管理部に指示を出し、温度管理部を作動させ熱交換部(30)により保存液を適宜加熱冷却することなどで行うことができる。
上記温度制御した保存液で臓器を灌流することにより、臓器の組織を活性化させて劣化を抑制し、劣化した細胞を活性化することができる。
The temperature management unit includes a temperature measurement unit (29), a heat exchange unit (30) for heating and cooling the storage liquid, and a signal for adjusting the temperature set based on data from the temperature measurement unit to the heat exchange unit. It consists of a central processor (not shown) of the adjusting unit for transmission. The temperature measuring unit (29) can be composed of a normal thermocouple thermometer, and the heat exchanging unit can heat and cool the storage solution through a pipe for circulating the storage solution. A heating mechanism or a cooling mechanism can be used without particular limitation. The pipe is provided with a pump (31) and a filter (32) for removing impurities from the storage solution.
At this time, the temperature management unit (29) performs temperature control so that the temperature of the preservation solution stored in the organ preservation unit (19) is gradually heated and / or cooled to a predetermined temperature.
The predetermined temperature is preferably 4 ° C to 25 ° C.
Temperature control is performed by gradually increasing the temperature from 4 ° C. to 25 ° C. Specifically, the rate of temperature increase of the storage solution is the average rate over the entire temperature control time (total temperature change / total temperature). The control time is 0.15 to 0.25 ° C./min, and the temperature change amount per unit time (temperature change amount per unit minute) is 1.5 ° C./min to 0.01 ° C./min. It is preferable to control the temperature smoothly.
The temperature control can be performed by the adjustment unit (33) issuing an instruction to the temperature management unit, operating the temperature management unit, and appropriately heating and cooling the storage solution by the heat exchange unit (30).
By perfusing the organ with the above temperature-controlled storage solution, the organ tissue can be activated to suppress deterioration, and the deteriorated cells can be activated.

導入部(21)は、複数種類の薬剤(有効成分剤)を個別に保存しておけるように複数のタンク(22)が設けられており、それぞれのタンク(22)が導入配管部の導入管に配管及び注入ポンプを介して連結されており、各種薬剤を任意の量注入できるようになされている。
この際用いることができる薬剤(有効成分剤)としては、以下のもの等を挙げることができる。
例えば、炭水化物(グルコース、デキストロース)、酸素、水素、電解質(ナトリウム、カリウム、重炭酸塩、カルシウム、マグネシウム)、抗生物質や抗微生物剤(グラム陰性及びグラム陽性菌、ペニシリン)、ホルモン類(インシュリン、エピネフリン)、内因性代謝物質又は内因性代謝物質の前駆物質(アデノシン、L- アルギニン)、脂肪酸(飽和及び不飽和、単鎖及び長鎖)、薬学的に活性な薬剤(血管拡張剤、ヘパリン、ニトログリセリン、ACE阻害剤、ベータブロッカー、カルシウムチャンネルブロッカー、細胞保護剤、抗酸化剤、補体、抗補体、免疫抑制剤、非ステロイド系抗炎症剤、抗真菌薬、抗ウイルス薬、ステロイド類、ビタミン類、酵素、補酵素など)などが挙げられるが、これらに限定されない。pHを調節したり、溶液を安定化させたり、粘性を調節したりなどする他の構成成分も用いることもできる。
The introduction part (21) is provided with a plurality of tanks (22) so that a plurality of types of drugs (active ingredient agents) can be individually stored, and each tank (22) is an introduction pipe of the introduction piping part. Are connected to each other via a pipe and an injection pump so that various amounts of various drugs can be injected.
Examples of the drug (active ingredient) that can be used at this time include the following.
For example, carbohydrates (glucose, dextrose), oxygen, hydrogen, electrolytes (sodium, potassium, bicarbonate, calcium, magnesium), antibiotics and antimicrobials (gram negative and gram positive bacteria, penicillin), hormones (insulin, Epinephrine), endogenous metabolites or precursors of endogenous metabolites (adenosine, L-arginine), fatty acids (saturated and unsaturated, single chain and long chain), pharmaceutically active agents (vasodilators, heparin, Nitroglycerin, ACE inhibitor, beta blocker, calcium channel blocker, cytoprotective agent, antioxidant, complement, anti-complement, immunosuppressant, non-steroidal anti-inflammatory agent, antifungal agent, antiviral agent, steroids Vitamins, enzymes, coenzymes, etc.), but are not limited thereto. Other components such as adjusting the pH, stabilizing the solution and adjusting the viscosity can also be used.

機能評価部は、上述の流量計により構成されている。流量計(25)のデータを収集することで臓器の状態を把握することができる。特に導入管に配された流量計(25)のデータにより状態を把握することが可能となる。また、補助的に圧力計(26)のデータも用いることができるので圧力計(26)も機能評価部の構成要素として用いることができる。
いずれのデータも調整部(33)の中央プロセッサに入力されて、記憶媒体(図示せず)に格納されたデータベースまたはプログラムに照合されて評価されることにより保存されている臓器の状態を把握することになる。
The function evaluation unit is composed of the above-described flow meter. By collecting data from the flow meter (25), the state of the organ can be grasped. In particular, it is possible to grasp the state from the data of the flow meter (25) arranged in the introduction pipe. Moreover, since the data of a pressure gauge (26) can also be used supplementarily, a pressure gauge (26) can also be used as a component of a function evaluation part.
All the data is input to the central processor of the adjustment unit (33) and checked against a database or program stored in a storage medium (not shown) to evaluate the stored organ state. It will be.

調整部(33)は、特に図示しない中央プロセッサとデータベースまたはプログラムされた制御則や評価基準とが格納された記憶媒体とからなり、流量計および圧力計のデータを入力すると共に、評価を行った後、該評価に基づいて行う指示を熱交換部(30)と、導入管部及び排出管部のポンプ(図2中のPump)と、導入管部のエアトラップ(23、28)及び酸素添加管理部(24)と、導入部とに指示を出して、温度管理部の温度、並びに導入部に導入する有効成分剤の種類や導入量及び該保存液の流量を調節するようになされている。   The adjustment unit (33) includes a central processor (not shown) and a storage medium storing a database or a programmed control law and evaluation standard, and inputs data of a flow meter and a pressure gauge and performs an evaluation. After that, instructions to be performed based on the evaluation are the heat exchange section (30), the pumps of the introduction pipe section and the discharge pipe section (Pump in FIG. 2), the air traps (23, 28) of the introduction pipe section, and oxygen addition An instruction is given to the management unit (24) and the introduction unit to adjust the temperature of the temperature management unit, the type and amount of the active ingredient introduced into the introduction unit, and the flow rate of the preservation solution. .

そして、本実施形態の臓器保存装置は、以下のようにして使用することができる。
まず、図2で示すように、人体から分離した臓器、本実施形態においては肝臓(18)を、臓器保持部(19)の内部に保存液が一様に潅流できるよう載置する。そして、図2で示すように、載置した肝臓(18)の肝動脈や門脈に導入管部の導入管の端部を連結する。また、図2で示すように臓器保持部(19)中に、排出管部の排出管の端部を連結する。
ついで、移送ポンプなどを作動させて保存液灌流部(20)を作動させ、保存液を灌流させる。この際、温度管理部も作動させて、熱交換部により保存液を適宜加熱冷却して保存液を適温に制御する。温度の制御は、上述したように好ましい温度上昇の速度で温度が上昇するように加温及び/又は冷却し、初期温度好ましくは4℃〜25℃へと温度を上昇させる。
また、機能評価部(例えば、流量計(25)や圧力センサ(26))を作動させて臓器の応対を把握し、臓器が劣化していると判断される場合には、調整部からの指示により温度管理部の温度、並びに導入部に導入する有効成分剤の種類や導入量及び該保存液の流量を調節する。
そして、機能評価部の評価と調整部による調整は、以下のようにして行われる。
図3に示すように、流量計から得られる灌流流量情報及び灌流圧力情報を中央プロセッサへと送致する。ついで、中央プロセッサであらかじめ設定されたデータベースまたはプログラムされた制御則や評価基準に照合して臓器の機能の劣化を評価し、移植に支障が生じると判断される場合には臓器の機能を改善するように移送ポンプ、導入部、熱交換部に指示を出して、各種条件(保存液の液性(pH,含有糖質鎖状長さ制御成分量,粘度,血管拡張作用薬剤量,血管収縮薬剤量,細胞栄養成分,酸素添加量,各種イオン量),保存液温度,流量,圧力を制御する。
And the organ preservation apparatus of this embodiment can be used as follows.
First, as shown in FIG. 2, the organ separated from the human body, in this embodiment, the liver (18) is placed inside the organ holder (19) so that the preservation solution can be perfused uniformly. Then, as shown in FIG. 2, the end of the introduction tube of the introduction tube is connected to the hepatic artery or portal vein of the placed liver (18). Moreover, as shown in FIG. 2, the end part of the discharge pipe of the discharge pipe part is connected to the organ holding part (19).
Next, a transfer pump or the like is operated to operate the preservation solution perfusion section (20), and the preservation solution is perfused. At this time, the temperature management unit is also operated, and the storage solution is appropriately heated and cooled by the heat exchange unit to control the storage solution at an appropriate temperature. As described above, the temperature is controlled by heating and / or cooling so as to increase the temperature at a preferable rate of temperature increase, and increasing the temperature to the initial temperature, preferably 4 ° C. to 25 ° C.
In addition, when the function evaluation unit (for example, the flow meter (25) or the pressure sensor (26)) is operated to grasp the response of the organ, and it is determined that the organ has deteriorated, an instruction from the adjustment unit Thus, the temperature of the temperature control unit, the type and amount of the active ingredient introduced into the introduction unit, and the flow rate of the preservation solution are adjusted.
And evaluation of a function evaluation part and adjustment by an adjustment part are performed as follows.
As shown in FIG. 3, the perfusion flow rate information and perfusion pressure information obtained from the flow meter are sent to the central processor. Next, the deterioration of the organ function is evaluated by checking against a database set in advance by the central processor or programmed control rules and evaluation criteria, and if it is judged that transplantation will be hindered, the organ function is improved. Instructions to the transfer pump, introduction part, heat exchanging part, various conditions (liquidity of preservation solution (pH, amount of sugar chain length control component, viscosity, amount of vasodilator, amount of vasoconstrictor) Volume, cellular nutrient components, oxygen addition amount, various ion amounts), preservation solution temperature, flow rate, and pressure.

本実施形態の生体から取り出した臓器を保存し、且つ保存中の臓器の状態を解析して最適な保存状態を選択できる。   An organ taken out from the living body of the present embodiment can be stored, and the state of the organ being stored can be analyzed to select an optimal storage state.

なお、本発明は上述の実施形態に何ら制限されるものではなく、本発明の趣旨を逸脱しない範囲で種々変更可能である。
たとえば、ヒトの臓器(肝臓など)だけでなく、哺乳動物の臓器(例えばブタの肝臓など)でも、本発明の臓器保存装置を用いることが可能である。
The present invention is not limited to the above-described embodiment, and various modifications can be made without departing from the spirit of the present invention.
For example, the organ storage device of the present invention can be used not only in human organs (eg, liver) but also in mammalian organs (eg, pig liver).

以下、本発明について実施例及び比較例を示してさらに具体的に説明するが、本発明はこれらに何ら制限されるものではない。   EXAMPLES Hereinafter, although an Example and a comparative example are shown and this invention is demonstrated more concretely, this invention is not restrict | limited at all to these.

〔実施例1〕温阻血処理後の肝臓を、臓器保存装置を用い、低温から徐々に復温させる灌流による臓器保存
臓器保存装置としては、図2に示す装置を用いた。
最初に保存液としてのウィスコンシン大学溶液を基本とした成分を臓器蘇生のために調整した溶液1.5リットルで臓器保存装置の臓器保持部(19)を満たした。
次に、温度管理部を4℃に設定し、作動させ、上記保存液の温度を4℃にした。
実験動物として、ブタ(大ヨークシャー種、デュロック種雑種種、体重20kg、2〜3ヶ月令)を、倫理的規則を尊守して試験に用いた。
まず、ブタを麻酔下において開腹し、門脈と肝動脈とを結紮することにより、肝臓の温阻血処理が60分間となるように肝臓600〜700gを摘出した。
次に、臨床利用されている低温単純冷却保存に相当する操作として肝臓を4℃の保存液中で2時間低温単純冷却保存を行った。低温単純冷却保存中は保存液の還流は行わなかった。
低温単純冷却保存終了後、 摘出した肝臓を、保存液を投入した臓器保持部(19)に設置し、各管を連結させた。
連結は、保存液灌流部(20)の肝動脈用の導入管の1端部を肝動脈に挿入し、保存液灌流部(20)の肝門脈用の導入管の1端部を肝門脈に挿入することにより行った。また、各導入管の他端部を保存液中に浸漬するように設置した。
低温単純冷却保存終了後、肝臓に対する保存液の灌流を行った。灌流は、臓器保存装置を用いて、以下の条件で行った。
灌流の条件:
保存液の温度:4℃から22℃に平均0.2℃/分の速度で加温(加温は、熱交換器(30)に保存液を流通させて行った)
酸素添加装置での酸素供給条件:8mg/L以上を維持(飽和溶存酸素量を維持)
ポンプ流速(肝動脈用):0.22mL/min/g
ポンプ流速(肝門脈用):0.06mL/min/g
時間:2時間
(肝臓の状態の評価)
肝臓の状態の評価は、灌流中に肝臓が保存液中に放出したラクトースデハイドロゲナーゼ(LDH)の量を指標として行った。
LDHは細胞内に存在する酵素で、細胞障害などで細胞膜が破壊されることにより細胞外に放出される酵素である。このため、放出されたLDHの量を測定することにより、細胞障害の程度を把握することができる。
LDH量の放出量を算出するために灌流開始時及び灌流開始2時間後の保存液中のLDH量を常法に従って測定した。
また、LDHの放出量を以下の式により算出した。
LDHの放出量=(灌流開始2時間後のLDH量−灌流開始時のLDH量)
LDHの放出量の結果を図4に示す。
[Example 1] The organ shown in FIG. 2 was used as an organ preservation organ preservation device by perfusion in which the liver after warm ischemia treatment was gradually reheated from a low temperature using an organ preservation device.
First, the organ holding part (19) of the organ preservation device was filled with 1.5 liters of a solution prepared by preparing components based on the University of Wisconsin solution as a preservation solution for organ resuscitation.
Next, the temperature control part was set to 4 ° C. and operated, and the temperature of the preservation solution was set to 4 ° C.
As experimental animals, pigs (large Yorkshire species, Duroc hybrids , body weight 20 kg, 2-3 months old ) were used in the test in accordance with ethical rules.
First, the pig was laparotomized under anesthesia, and the portal vein and the hepatic artery were ligated to remove 600 to 700 g of the liver so that the warm ischemic treatment of the liver was 60 minutes.
Next, the liver was subjected to low-temperature simple cold storage for 2 hours in a preservation solution at 4 ° C. as an operation corresponding to low-temperature simple cold storage used clinically. During the low-temperature simple cooling storage, the storage solution was not refluxed.
After completion of the low-temperature simple cooling storage, the removed liver was placed in the organ holding part (19) into which the storage solution was introduced, and the tubes were connected.
For connection, one end of the hepatic artery introduction tube of the preservation solution perfusion part (20) is inserted into the hepatic artery, and one end of the preservation solution perfusion part (20) of the introduction tube for the hepatic portal vein is connected to the hepatic portal. This was done by inserting into the pulse. Moreover, it installed so that the other end part of each inlet tube might be immersed in a preservation | save liquid.
After completion of the low-temperature simple cooling storage, the preservation solution was perfused into the liver. Perfusion was performed under the following conditions using an organ preservation device.
Perfusion conditions:
Temperature of preservation solution: Heated from 4 ° C. to 22 ° C. at an average rate of 0.2 ° C./minute (heating was performed by circulating the preservation solution through the heat exchanger (30))
Oxygen supply condition in oxygen addition device: Maintain 8 mg / L or more (maintain saturated dissolved oxygen content)
Pump flow rate (for hepatic artery): 0.22 mL / min / g
Pump flow rate (for hepatic portal vein): 0.06 mL / min / g
Time: 2 hours (evaluation of liver condition)
The liver condition was evaluated using the amount of lactose dehydrogenase (LDH) released by the liver into the preservation solution during perfusion as an index.
LDH is an enzyme that is present in the cell and is released outside the cell membrane due to cell damage. Therefore, the degree of cell damage can be grasped by measuring the amount of released LDH.
In order to calculate the amount of LDH released, the amount of LDH in the preservation solution at the start of perfusion and 2 hours after the start of perfusion was measured according to a conventional method.
In addition, the amount of LDH released was calculated by the following formula.
LDH release amount = (LDH amount 2 hours after the start of perfusion-LDH amount at the start of perfusion)
The result of LDH release amount is shown in FIG.

〔実施例2〕温阻血処理なしの条件で、臓器保存装置を用い、低温で灌流を行った臓器保存
肝臓の温阻血処理を行わず、実施例1と同様にして低温処理を行い、保存液の温度を4℃の条件で灌流を行い、実施例1と同様にしてLDHの放出量を測定した。その結果を図4に示す。
[Example 2] Organ preservation that was perfused at a low temperature using an organ preservation device under conditions without a warm ischemia treatment. A cold preservation treatment was performed in the same manner as in Example 1 without performing a warm ischemia treatment of the liver. The perfusion was carried out at a temperature of 4 ° C., and the amount of LDH released was measured in the same manner as in Example 1. The result is shown in FIG.

〔実施例3〕温阻血処理後の肝臓を、臓器保存装置を用い、低温で灌流を行った臓器保存
実施例1と同様にして肝臓の温阻血処理を行い、実施例1と同様にして低温処理を行い、保存液の温度を4℃の条件で灌流を行い、実施例1と同様にしてLDHの放出量を測定した。その結果を図4に示す。
[Example 3] Liver ischemic treatment was performed on the liver after organ perfusion was performed at low temperature using an organ preservation device. Liver ischemic treatment was performed in the same manner as in Example 1, and the liver was treated at low temperature as in Example 1. The treatment was performed, and the preservation solution was perfused at a temperature of 4 ° C., and the amount of LDH released was measured in the same manner as in Example 1. The result is shown in FIG.

図4に示す結果から、いずれの例も臓器保存の状態が良好であり、臓器保存装置として有用であることがわかるが、特に、本発明の臓器保存装置を用い、温阻血処理後の肝臓を低温から徐々に復温させる灌流による臓器保存を行った例(実施例1)は、低温で灌流を行った臓器保存の例(実施例3)と比較して、LDHの放出量が少なく、組織の障害が少ないことがわかる。
また、本発明の臓器保存装置を用い灌流により、温阻血処理後低温から徐々に復温した場合(実施例1)は、温阻血処理を行わず低温で灌流を行った場合(実施例2)に比しても、LDHの放出量に有意な差が見られず、組織の障害が少ないことがわかる。

From the results shown in FIG. 4, it can be seen that any of the examples has a good organ preservation state and is useful as an organ preservation device. In particular, using the organ preservation device of the present invention, Example (Example 1) in which organ preservation by perfusion gradually recovering from a low temperature has a smaller LDH release amount than tissue preservation example (Example 3) in which perfusion was performed at low temperature, and tissue It turns out that there are few obstacles.
In addition, when the temperature is gradually recovered from the low temperature after the warm ischemia treatment by perfusion using the organ preservation apparatus of the present invention (Example 1), the perfusion is performed at a low temperature without performing the warm ischemia treatment (Example 2). Even when compared to, the significant amount of LDH release is not seen, indicating that there is little tissue damage.

Claims (3)

生体から分離した臓器を灌流保存する臓器保存装置であって、
臓器を保持する臓器保持部と、
臓器保持部に保持されている臓器に臓器保存用の保存液を灌流させる保存液灌流部と、
臓器保存部の温度管理を行う温度管理部と、
保存液灌流部に流通させる保存液に有効成分剤を導入する導入部と、
臓器に灌流させる保存液の流量や圧力を測定することで臓器の機能を評価する機能評価部と、
機能評価により得られたデータに基づいて温度管理部の温度、並びに導入部により導入される有効成分剤の種類や導入量及び該保存液の流量を調節する調整部と
を具備してなる臓器保存装置。
An organ preservation device for perfusion preservation of an organ separated from a living body,
An organ holding unit for holding the organ;
A preservation solution perfusion section for perfusing an preservation solution for organ preservation into an organ held in the organ holding section;
A temperature management unit for managing the temperature of the organ preservation unit;
An introduction part for introducing an active ingredient into a preservation solution to be distributed to the preservation solution perfusion part;
A function evaluation unit that evaluates the function of the organ by measuring the flow rate and pressure of the preservation solution to be perfused into the organ;
Organ preservation comprising a temperature control part based on data obtained by functional evaluation, and an adjustment part for adjusting the type and amount of active ingredient introduced by the introduction part and the flow rate of the preservation solution apparatus.
上記温度管理部は、上記臓器保存部内に貯留される保存液の温度を4℃〜25℃まで徐々に加温及び/又は冷却するように温度制御する
ことを特徴とする請求項1記載の臓器保存装置。
The organ according to claim 1, wherein the temperature management unit controls the temperature of the preservation solution stored in the organ preservation unit so as to gradually warm and / or cool the temperature of the preservation solution from 4 ° C to 25 ° C. Storage device.
請求項1記載の臓器保存装置を用いる臓器保存方法であって、
臓器保存部の温度を4℃〜25℃まで徐々に加温及び/又は冷却することを特徴とする
臓器保存方法。



An organ preservation method using the organ preservation device according to claim 1,
An organ preservation method comprising gradually warming and / or cooling the temperature of an organ preservation part from 4 ° C to 25 ° C.



JP2012197158A 2011-09-15 2012-09-07 Organ preservation device Pending JP2013075888A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012197158A JP2013075888A (en) 2011-09-15 2012-09-07 Organ preservation device

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011220498 2011-09-15
JP2011220498 2011-09-15
JP2012197158A JP2013075888A (en) 2011-09-15 2012-09-07 Organ preservation device

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017183855A Division JP6405016B2 (en) 2011-09-15 2017-09-25 Organ preservation device

Publications (1)

Publication Number Publication Date
JP2013075888A true JP2013075888A (en) 2013-04-25

Family

ID=48479648

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012197158A Pending JP2013075888A (en) 2011-09-15 2012-09-07 Organ preservation device
JP2017183855A Active JP6405016B2 (en) 2011-09-15 2017-09-25 Organ preservation device

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017183855A Active JP6405016B2 (en) 2011-09-15 2017-09-25 Organ preservation device

Country Status (1)

Country Link
JP (2) JP2013075888A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2937415A1 (en) 2014-03-31 2015-10-28 Sysmex Corporation Method for obtaining differentiated cells and/or differentiated cell products from undifferentiated cell
CN105413783A (en) * 2016-01-19 2016-03-23 上海海洋大学 Low-temperature platform for in-vitro electrophysiological recording
WO2017200089A1 (en) * 2016-05-20 2017-11-23 株式会社Screenホールディングス Perfusion apparatus for liver for transplantation, and liver isolation method and liver transplantation method using said apparatus
CN109380213A (en) * 2018-11-28 2019-02-26 西安交通大学医学院第附属医院 A kind of in vitro animal viscera device for casting
JP2019048652A (en) * 2017-09-08 2019-03-28 株式会社ジェイ・エム・エス Transport device for organ and biological tissue
JPWO2019064443A1 (en) * 2017-09-28 2020-11-26 3C株式会社 Organ preservation method and organ transplantation method
CN114946838A (en) * 2022-06-29 2022-08-30 上海健耕医药科技股份有限公司 Liver low-temperature perfusion preservation device and method
JP7406211B2 (en) 2020-10-14 2023-12-27 株式会社島津製作所 Organ perfusion device and control method

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020002062A (en) * 2018-06-28 2020-01-09 株式会社Screenホールディングス Perfusion device and perfusion method
JP2023084756A (en) * 2021-12-08 2023-06-20 株式会社Screenホールディングス Organ preservation apparatus and organ preservation method

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6061501A (en) * 1983-09-14 1985-04-09 Hoxan Corp Method for preserving viscus
JPS6061502A (en) * 1983-09-14 1985-04-09 Hoxan Corp Perfusion method and apparatus for preserving viscus
JPS6061503A (en) * 1983-09-14 1985-04-09 Hoxan Corp Method for preserving viscus
JPH01211501A (en) * 1988-02-19 1989-08-24 Hoxan Corp Method and apparatus for preserving organ
JPH049301A (en) * 1990-04-26 1992-01-14 Olympus Optical Co Ltd Internal organ-preserving device
JPH07196401A (en) * 1993-12-15 1995-08-01 Dr Karl Thomae Gmbh Method, apparatus and perfusate for preservation of organ for transplantation
JP2001516768A (en) * 1997-09-23 2001-10-02 ハッサネイン,ワリード,エイチ. Compositions, methods and devices for maintaining organs
US20020012988A1 (en) * 1999-04-14 2002-01-31 Lauren Brasile Organ chamber for exsanguinous metabolic support system
JP2004513889A (en) * 2000-08-25 2004-05-13 オルガン リカヴァリー システムス インコーポレイテッド Apparatus and method for maintaining and / or restoring organ viability
JP2010520207A (en) * 2007-03-01 2010-06-10 ライフライン サイエンティフィック インコーポレイテッド Perfusion regulation
US20110003275A1 (en) * 2007-07-06 2011-01-06 Igelosa Transplantation Science Ab System and method for organ evaluation and preservation
JP2011520839A (en) * 2008-05-14 2011-07-21 フンダシオ プリバダ クリニク ペル ア ラ レセルカ ビオメディカ Device for preservation of liver grafts at normal body temperature

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6061501A (en) * 1983-09-14 1985-04-09 Hoxan Corp Method for preserving viscus
JPS6061502A (en) * 1983-09-14 1985-04-09 Hoxan Corp Perfusion method and apparatus for preserving viscus
JPS6061503A (en) * 1983-09-14 1985-04-09 Hoxan Corp Method for preserving viscus
JPH01211501A (en) * 1988-02-19 1989-08-24 Hoxan Corp Method and apparatus for preserving organ
JPH049301A (en) * 1990-04-26 1992-01-14 Olympus Optical Co Ltd Internal organ-preserving device
JPH07196401A (en) * 1993-12-15 1995-08-01 Dr Karl Thomae Gmbh Method, apparatus and perfusate for preservation of organ for transplantation
JP2001516768A (en) * 1997-09-23 2001-10-02 ハッサネイン,ワリード,エイチ. Compositions, methods and devices for maintaining organs
US20020012988A1 (en) * 1999-04-14 2002-01-31 Lauren Brasile Organ chamber for exsanguinous metabolic support system
JP2004513889A (en) * 2000-08-25 2004-05-13 オルガン リカヴァリー システムス インコーポレイテッド Apparatus and method for maintaining and / or restoring organ viability
JP2010520207A (en) * 2007-03-01 2010-06-10 ライフライン サイエンティフィック インコーポレイテッド Perfusion regulation
US20110003275A1 (en) * 2007-07-06 2011-01-06 Igelosa Transplantation Science Ab System and method for organ evaluation and preservation
JP2011520839A (en) * 2008-05-14 2011-07-21 フンダシオ プリバダ クリニク ペル ア ラ レセルカ ビオメディカ Device for preservation of liver grafts at normal body temperature

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10184109B2 (en) 2014-03-31 2019-01-22 Sysmex Corporation Method for obtaining differentiated cells and/or differentiated cell products from undifferentiated cell and a method of perfusion culture
JP2015198644A (en) * 2014-03-31 2015-11-12 シスメックス株式会社 Method of obtaining differentiated cell and/or product of differentiated cell from undifferentiated cell
EP2937415A1 (en) 2014-03-31 2015-10-28 Sysmex Corporation Method for obtaining differentiated cells and/or differentiated cell products from undifferentiated cell
CN105413783A (en) * 2016-01-19 2016-03-23 上海海洋大学 Low-temperature platform for in-vitro electrophysiological recording
JPWO2017200089A1 (en) * 2016-05-20 2019-03-14 株式会社Screenホールディングス Device for perfusion of liver for transplantation, and method of liver removal and liver transplantation using the device
WO2017200089A1 (en) * 2016-05-20 2017-11-23 株式会社Screenホールディングス Perfusion apparatus for liver for transplantation, and liver isolation method and liver transplantation method using said apparatus
JP2019048652A (en) * 2017-09-08 2019-03-28 株式会社ジェイ・エム・エス Transport device for organ and biological tissue
JPWO2019064443A1 (en) * 2017-09-28 2020-11-26 3C株式会社 Organ preservation method and organ transplantation method
CN109380213A (en) * 2018-11-28 2019-02-26 西安交通大学医学院第附属医院 A kind of in vitro animal viscera device for casting
JP7406211B2 (en) 2020-10-14 2023-12-27 株式会社島津製作所 Organ perfusion device and control method
CN114946838A (en) * 2022-06-29 2022-08-30 上海健耕医药科技股份有限公司 Liver low-temperature perfusion preservation device and method
WO2024001176A1 (en) * 2022-06-29 2024-01-04 上海健耕医药科技股份有限公司 Hypothermic liver perfusion preservation device and method
CN114946838B (en) * 2022-06-29 2024-06-04 上海健耕医药科技股份有限公司 Liver low-temperature perfusion preservation device and method

Also Published As

Publication number Publication date
JP6405016B2 (en) 2018-10-17
JP2017218463A (en) 2017-12-14

Similar Documents

Publication Publication Date Title
JP6405016B2 (en) Organ preservation device
Vogel et al. The 24‐hour normothermic machine perfusion of discarded human liver grafts
CA2620328C (en) Machine perfusion of tissue grafts for transplantation
Nassar et al. Ex vivo normothermic machine perfusion is safe, simple, and reliable: results from a large animal model
JP5592876B2 (en) Device for preservation of liver grafts at normal body temperature
BR112013031607B1 (en) METHOD OF DETERMINING PARAMETERS TO MAINTAIN THE VIABILITY OF A LIVER OR A KIDNEY AND METHOD OF TRANSPORTING AND/OR STORING AT LEAST ONE LIVER
EP2337449B1 (en) Method and instrument for vitrification and storing of biological specimen
JP2004503473A (en) Cryopreservation of bioactive materials using high-temperature freezing
JP2017218463A5 (en)
CN115460915A (en) Systems and methods for organ maintenance and transport
US10834919B2 (en) Cryopreservation instrument and method of using same
van Leeuwen et al. Viability criteria for functional assessment of donor livers during normothermic machine perfusion
Dirkes et al. A novel oxygenated machine perfusion system for preservation of the liver
Gilbo et al. Porcine liver normothermic machine perfusion: methodological framework and potential pitfalls
Fernandes et al. Alternative solution for ex vivo lung perfusion, experimental study on donated human lungs non-accepted for transplantation
CN105532638A (en) Instrument apparatus for low-temperature storage of biological material
Nakamoto et al. A study on optimal temperature for isolated lung preservation
US20210195891A1 (en) Cryopreservation of tissues and organs
Fonouni et al. Evaluating the effects of extended cold ischemia on interstitial metabolite in grafts in kidney transplantation using microdialysis
JP2016160247A (en) Organ preservation device, blood flow determination device and blood flow state determination method
JP2017186295A (en) Organ preservation method and organ transplantation method
MacConmara et al. Machine Perfusion in Liver Transplantation
Michailov et al. Methods to improve frozen-thawed blastocyst transfer outcomes-the IVF laboratory perspective
Navarro et al. Peritoneal cooling may provide improved protection for uncontrolled donors after cardiac death: an exploratory porcine study
CN215454964U (en) Novel cell cryopreserving device

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150821

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160219

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160517

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160715

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161115

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170113

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170116

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170627